Besides FAPI homodimers (e.g. DOTA(SA.FAPi)2, DOTAGA.(SA.FAPi)2); heterodimers such as FAPI-RGD (arginine-glycine-aspartate) targeting both FAP and αvβ3 were also developed to enhance tumour uptake and retention [27]. Here, FAP is linked to neoplasm.